While efforts to find a coronavirus vaccine have already started globally, the SII-Codagenix candidate vaccine, developed using a laboratory-made synthetic virus, is an important breakthrough because it could significantly reduce the time taken to build a shield against the virus at the heart of the current outbreak emanating from China.
